Literature DB >> 6386027

Differences in tumour necrosis factor productive ability among rodents.

K Haranaka, N Satomi, A Sakurai.   

Abstract

Large differences in tumour necrosis factor (TNF) productive ability 05337257erved among various strains of mice. DDY, CD-1, ICR and DBA/2 mice could produce a high titre of TNF activity, whereas Balb/c, C3H/HeJms and A/J mice produced a low titre of TNF activity. Administration of 200 micrograms/mouse of LPS to some strains of mice, i.e. DDD and C57B1/6J resulted in good production of TNF. ICR nu/nu mice produced the highest TNF activity among the nude mice. Balb/c nu/nu and DDD nu/nu mice exhibited very low titres of TNF activity. Nude mice required a rather higher dose of the priming agent, Propionibacterium acnes, than heterozygote littermates. Although it is commonly accepted that dual stimulation is necessary for TNF production, TNF activity was detected without the priming agent in SD rats and Golden hamsters by single injection of LPS. In these animals, much higher TNF production was observed after Propionibacterium acnes treatment than after a single injection of LPS. Large differences in TNF productive ability also existed among strains of rats. Although all animals receiving priming agents revealed hyperplasia of reticuloendothelial system, the sensitivity of the animals to LPS is considered to be the most important factor in their TNF productive ability.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6386027      PMCID: PMC1976898          DOI: 10.1038/bjc.1984.203

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  16 in total

1.  Tumor necrosis factor.

Authors:  L J Old
Journal:  Clin Bull       Date:  1976

2.  Macrophages activated in vitro with lymphocyte mediators kill neoplastic but not normal cells.

Authors:  W F Piessens; W H Churchill
Journal:  J Immunol       Date:  1975-01       Impact factor: 5.422

3.  Vascular reactions of normal and malignant tissues in vivo. V. The rôle of hypotension in the action of a bacterial polysaccharide on tumors.

Authors:  G H ALGIRE; F Y LEGALLAIS; B F ANDERSON
Journal:  J Natl Cancer Inst       Date:  1952-06       Impact factor: 13.506

4.  Macrophages as a source of tumoricidal activity (tumor-necrotizing factor).

Authors:  D N Männel; R N Moore; S E Mergenhagen
Journal:  Infect Immun       Date:  1980-11       Impact factor: 3.441

5.  Defective tumoricidal capacity of macrophages from A/J mice. III. Genetic analysis of the macrophage defect.

Authors:  D Boraschi; M S Meltzer
Journal:  J Immunol       Date:  1980-03       Impact factor: 5.422

6.  Dose, route, and time dependence of serum lysozyme and antitumor activity following administration of glucan, Corynebacterium parvum, pyran, or lipopolysaccharide to mice.

Authors:  A Gorecka-Tisera; J W Proctor; Y Yamamura; J Harnaha; K Meinert
Journal:  J Natl Cancer Inst       Date:  1981-10       Impact factor: 13.506

7.  Research on the production site of tumor necrosis factor (TNF).

Authors:  N Satomi; K Haranaka; O Kunii
Journal:  Jpn J Exp Med       Date:  1981-12

8.  Sensitivity of mice to endotoxin after vaccination with BCG (Bacillus Calmette-Guérin).

Authors:  E SUTER; G E ULLMAN; R G HOFFMAN
Journal:  Proc Soc Exp Biol Med       Date:  1958-10

9.  Tumour-necrosis factor from the rabbit. I. Mode of action, specificity and physicochemical properties.

Authors:  N Matthews; J F Watkins
Journal:  Br J Cancer       Date:  1978-08       Impact factor: 7.640

10.  Tumour-necrosis factor from the rabbit. II. Production by monocytes.

Authors:  N Matthews
Journal:  Br J Cancer       Date:  1978-08       Impact factor: 7.640

View more
  8 in total

1.  Role of tumour necrosis factor in the tumour-necrotizing activity of agents with diverging toxicity.

Authors:  P A van de Wiel; A van der Pijl; N Bloksma
Journal:  Cancer Immunol Immunother       Date:  1991       Impact factor: 6.968

2.  DNA polymorphism in cytokine genes based on length variation in simple-sequence tandem repeats.

Authors:  C O Jacob; K Mykytyn; N Tashman
Journal:  Immunogenetics       Date:  1993       Impact factor: 2.846

3.  Effects of injection routes of growing tumors and PSK or OK-432 on antiproliferative activity of mouse serum.

Authors:  C Ryoyama; K Ryoyama
Journal:  Cancer Immunol Immunother       Date:  1989       Impact factor: 6.968

4.  Purification, characterization, and antitumor activity of nonrecombinant mouse tumor necrosis factor.

Authors:  K Haranaka; E A Carswell; B D Williamson; J S Prendergast; N Satomi; L J Old
Journal:  Proc Natl Acad Sci U S A       Date:  1986-06       Impact factor: 11.205

5.  Macrophage cytotoxicity in lethal and non-lethal murine malaria and the effect of vaccination.

Authors:  J Taverne; J D Treagust; J H Playfair
Journal:  Clin Exp Immunol       Date:  1986-10       Impact factor: 4.330

6.  Tumour necrosis factor and the lysosomal enzymes of macrophages or macrophage-like cell line.

Authors:  A Sakurai; N Satomi; K Haranaka
Journal:  Cancer Immunol Immunother       Date:  1985       Impact factor: 6.968

7.  Antitumor activities and tumor necrosis factor producibility of traditional Chinese medicines and crude drugs.

Authors:  K Haranaka; N Satomi; A Sakurai; R Haranaka; N Okada; M Kobayashi
Journal:  Cancer Immunol Immunother       Date:  1985       Impact factor: 6.968

8.  Effects of airway exposure to nanoparticles on lung inflammation induced by bacterial endotoxin in mice.

Authors:  Ken-Ichiro Inoue; Hirohisa Takano; Rie Yanagisawa; Seishiro Hirano; Miho Sakurai; Akinori Shimada; Toshikazu Yoshikawa
Journal:  Environ Health Perspect       Date:  2006-09       Impact factor: 9.031

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.